Sleep Disorders: Clinical Trials

8 trials for Sleep Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 31Completed 1

Follow Sleep Disorders: new trials by email Literature Review of Sleep Disorders trials Research Report on Sleep Disorders

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders
NPC-15 Granules Lower Dose, NPC-15 Granules Higher Dose, NPC-15 Placebo Granule - Sleep Disorders, Autism Spectrum Disorder
Phase 2 / Phase 3CompletedNobelpharma1962016-06-162019-04-16
Does Melatonin Restore Sleep Architecture in Autistic Children
melatonin, Melatonin, placebo - Sleep Disorders
Phase 2CompletedHospices Civils de Lyon262014-06-012025-10-02
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
donepezil hydrochloride, Placebo - Anxiety Disorder, Breast Cancer
Phase 2CompletedWake Forest University Health Sciences622012-07-012021-10-20
Exploratory Subjective Sleep Study of a Prototype Nasal Dilator
Prototype Nasal Dilator, Marketed Nasal Strip, Placebo Nasal Strip - Sleep Disorders, Congestion, Nasal
Phase 2CompletedGlaxoSmithKline612009-10-012018-04-09
Vestipitant 28-day Tolerance Study
GW597599, Placebo - Sleep Disorders
Phase 2CompletedGlaxoSmithKline1612009-05-012016-10-28
Yoga in Treating Sleep Disturbance in Cancer Survivors
Standard Care Control Condition, Yoga Intervention (YOCAS) - Fatigue, Cancer
Phase 2CompletedGary Morrow4102006-10-012017-02-20
Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)
Dopamine Agonist and Exercise - Restless Legs Syndrome, End Stage Renal Disease
Phase 2CompletedUniversity of Thessaly462006-09-012010-07-05
Melatonin Supplements for Improving Sleep in Individuals With Hypertension
Melatonin, Placebo - Sleep Disorders, Hypertension
Phase 2CompletedBrigham and Women's Hospital162005-10-012017-11-14

Narrower conditions

Sleep Wake Disorders (8)  ·  Fatigue (2)  ·  Anxiety Disorders (1)  ·  Autism Spectrum Disorder (1)  ·  Breast Neoplasms (1)  ·  Cognition Disorders (1)  ·  Depression (1)  ·  Hypertension (1)  ·  Kidney Failure, Chronic (1)  ·  Motor Activity (1)  ·  Nasal Obstruction (1)  ·  Neoplasms (1)  ·  Restless Legs Syndrome (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Mental Disorders (8)  ·  Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (8)  ·  Behavior (2)  ·  Dyssomnias (2)  ·  Sleep Disorders, Intrinsic (2)  ·  Airway Obstruction (1)  ·  Behavioral Symptoms (1)  ·  Breast Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Child Development Disorders, Pervasive (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)

Interventions

Melatonin (3)  ·  Donepezil (1)  ·  Dopamine Agonists (1)  ·  Exercise (1)  ·  vestipitant (1)

Sponsors

GlaxoSmithKline (2)  ·  Brigham and Women's Hospital (1)  ·  Gary Morrow (1)  ·  Hospices Civils de Lyon (1)  ·  Nobelpharma (1)  ·  University of Thessaly (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (3)  ·  France (1)  ·  Germany (1)  ·  Greece (1)

Top investigators

Frank AJ Scheer, PhD (1)  ·  Giorgos K Sakkas, PhD (1)  ·  Ioannis Stefanidis, MD PhD (1)  ·  Julia A. Lawrence (1)  ·  Karen M. Mustian, PhD (1)  ·  Patricia Franco, MD (1)  ·  Yushiro Yamashita, MD, PhD (1)

Results publications

PMID 23024438, PMID 23929523, PMID 23940231, PMID 24024727, PMID 26262586, PMID 30154874, PMID 31165647, PMID 32912180, PMID 35018639, PMID 39368335, PMID 40421669

NIH funding

R21AT002713 (1), U10CA037420 (1), U10CA081851 (1)